Navigation Links
Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
Date:2/16/2009

g demand for our "Shengmingsu" products and rapid expansion of our sales network led to noteworthy revenue and profit growth," commented Mr. Zishen Wu, Chief Executive Officer of Yongye. "While overall economic growth in China is expected to slow in 2009, we believe, based on our experience and understanding of China's agricultural markets, that demand for our plant and animal nutrient products will continue to show strong growth. Our recently expanded production facilities and additional stores will ensure that we meet anticipated demand for our products in 2009. We are fully confident that we will achieve our 2009 make good targets of $66 million in revenue and $15.8 million in net income."

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patented and patent pending processes and proprietary formulas allow it to create products that increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia, People's Republic of China. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

The Company does not own any of its branded stores. Yongye works with distributors to target existing, independent agricultural stores which it believe meets its national branding criteria and then enters into agreements with storeowners through which the Company provides training about its products to storeowners and a computer to each store which contains educational and promotional information about the use of its products. Before becoming a Yongye branded store, stores are often physically cleaned and upgraded to meet the Company's national standards. Once a store becomes a Yongye brand
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Yongye Biotechnology to Host Virtual Retail Road Show to Provide Overview of the Company in English and Mandarin
2. Yongye Biotechnology International to Expand its Network of Branded Stores
3. Yongye Biotechnology to Present at Roth Conference
4. Yongye Biotechnology Announces Record Third Quarter Results
5. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
6. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
7. Yongye Biotechnology International Raises $9.4 Million in Private Placement
8. Yongye Biotechnology International Announces Second Quarter Results
9. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
10. Yongye Biotechnology International Retains CCG Investor Relations
11. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... that BioSpecifics, President, Tom Wegman, will present at the upcoming ... 16, 2009, at 9:00 am ET at the Millennium Broadway ... , A live webcast of the presentation can ...
... ... experiments to demonstrate the power of nanotechnology based regenerative medicines. , ... (PRWEB) September 11, 2009 -- Long-time ... attempt to rejuvenate living animals with advanced nanotechnologies developed by his labs. The goal ...
... SUNRISE, Fla., Sept. 10 Bioheart, Inc., (OTC ... and biologics that help monitor, diagnose and treat heart failure ... President of R&D and Corporate development has been invited to ... Maryland, this month. , , Ms. Comella ...
Cached Biology Technology:Matthew Sarad to Reverse Aging and Cure Cancer 2Matthew Sarad to Reverse Aging and Cure Cancer 3Matthew Sarad to Reverse Aging and Cure Cancer 4Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd 2Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd 3
(Date:4/17/2014)... A Kansas State University engineer has developed ... remotely detects improvised explosive devices. The same technique ... Dunn, the Steven M. and Kay L. Theede ... and nuclear engineering, and his research team have ... underground or in car trunks. The distance detection ...
(Date:4/17/2014)... parasites and pathogens that devastate honeybees in Europe, Asia ... but do not appear to be impacting native honeybee ... of researchers., The invasive pests include including Nosema ... African honeybees appear to be resilient to these invasive ... to control pests in Europe, Asia and the United ...
(Date:4/17/2014)... Researchers reporting in the Cell Press journal Current ... insects with rather novel sex lives. The Brazilian insects, ... genus Neotrogla , are the first example of ... reversal has been identified in several different animals, ... intromittent organ is also reversed," says Kazunori Yoshizawa from ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3In sex-reversed cave insects, females have the penises 2
... USA/BEIJING, CHINA -- The global fight against the tuberculosis ... China National Biotec Group (CNBG) announce that they have ... vaccines. The agreement between the leading non-profit developer of ... China signals a commitment by both to engage and ...
... UC Santa Barbara geochemist David Valentine and colleagues published a ... almost all of the deepwater methane plumes following the Deepwater ... they asked, could almost all of the lethal gas emitted ... new study published in the Proceedings of the National ...
... and the political instability in the region have kept researchers ... But Hyongki Lee, a University of Houston civil engineering researcher, ... mysterious region _ studying it from space. , Lee won,t ... plans to use unanalyzed satellite images to survey the basin,s ...
Cached Biology News:Aeras and CNBG sign agreement on tuberculosis vaccine R&D 2UCSB scientists say topography played key role in Deepwater Horizon disaster 2UCSB scientists say topography played key role in Deepwater Horizon disaster 3UCSB scientists say topography played key role in Deepwater Horizon disaster 4University of Houston wins NASA grant to study Congo River Basin 2
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
Mouse polyclonal antibody raised against a partial recombinant SYT4. NCBI Entrez Gene ID = 6860...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: